Individuals traveling to or working in countries with high or intermediate rates of hepatitis A |
Individuals with chronic liver disease |
Individuals with clotting factor disorders |
Men who have sex with men |
Illicit drug users (injection and non-injection) |
Individuals with close personal contact with an international adoptee from a country of high or intermediate endemicity during the first 60 days following arrival in the United States |
Individuals working with HAV-infected primates or with HAV in a research laboratory |
Individuals with recent exposure for post-exposure prophylaxis |